Pankaj Mohan
2017 - Outlook Therapeutics
In 2017, Pankaj Mohan earned a total compensation of $1.1M as Director, former Chairman, President and former Chief Executive Officer at Outlook Therapeutics, a 92% decrease compared to previous year.
Compensation breakdown
| Salary | $490,000 |
|---|---|
| Stock Awards | $555,942 |
| Other | $31,610 |
| Total | $1,077,551 |
Mohan received $555.9K in stock awards, accounting for 52% of the total pay in 2017.
Mohan also received $490K in salary and $31.6K in other compensation.
Rankings
In 2017, Pankaj Mohan's compensation ranked 8,630th out of 14,666 executives tracked by ExecPay. In other words, Mohan earned more than 41.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,630 out of 14,666 | 41st |
Division Manufacturing | 3,279 out of 5,772 | 43rd |
Major group Chemicals And Allied Products | 1,102 out of 2,075 | 47th |
Industry group Drugs | 874 out of 1,731 | 50th |
Industry Biological Products, Except Diagnostic Substances | 155 out of 313 | 51st |
Source: SEC filing on August 17, 2018.
Mohan's colleagues
We found two more compensation records of executives who worked with Pankaj Mohan at Outlook Therapeutics in 2017.
News
Chanticleer Holdings CEO Pankaj Mohan's 2023 pay rises 2% to $1M
August 19, 2024
Chanticleer Holdings CEO Pankaj Mohan's 2022 pay jumps 27% to $1M
August 7, 2023
Chanticleer Holdings CEO Pankaj Mohan's 2021 pay falls 58% to $792K
April 11, 2022
Outlook Therapeutics CEO Pankaj Mohan's 2018 pay rises 14% to $1.2M
August 1, 2019